Barbara Gayle Duncan Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Barbara Gayle Duncan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Barbara Gayle Duncan. Barbara Gayle Duncan is Chief Financial Officer in INTERCEPT PHARMACEUTICALS INC ($ICPT).
Latest Insider Trading Transactions of Barbara Gayle Duncan
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 03 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,298 | 0 | 11,683 | |
| Oct 03 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 0.00 | 1,298 | 0 | 9,410 | 8.1 K to 9.4 K (+16.00 %) |
| Jul 10 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 9.82 | 25,000 | 245,558 | 19,520 | |
| Jul 10 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 45.39 | 25,000 | 1,134,840 | 8,112 | 33.1 K to 8.1 K (-75.50 %) |
| Jul 10 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 9.82 | 25,000 | 245,558 | 33,112 | 8.1 K to 33.1 K (+308.19 %) |
| Jul 03 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,298 | 0 | 12,981 | |
| Jul 03 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 0.00 | 1,298 | 0 | 8,112 | 6.8 K to 8.1 K (+19.05 %) |
| Jun 21 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 9.82 | 42,018 | 412,713 | 44,520 | |
| Jun 21 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 8.67 | 8,557 | 74,161 | 8,940 | |
| Jun 21 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 34.50 | 50,575 | 1,744,838 | 6,814 | 57.4 K to 6.8 K (-88.13 %) |
| Jun 21 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 9.82 | 42,018 | 412,713 | 56,759 | 14.7 K to 56.8 K (+285.04 %) |
| Jun 21 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 8.67 | 8,557 | 74,161 | 14,741 | 6.2 K to 14.7 K (+138.37 %) |
| May 28 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 8.67 | 4,915 | 42,597 | 17,497 | |
| May 28 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 8.67 | 1,200 | 10,400 | 22,412 | |
| May 28 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 8.67 | 110 | 953 | 23,612 | |
| May 28 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 34.50 | 4,915 | 169,568 | 6,814 | 11.7 K to 6.8 K (-41.90 %) |
| May 28 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 8.67 | 4,915 | 42,597 | 11,729 | 6.8 K to 11.7 K (+72.13 %) |
| May 28 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 34.50 | 1,200 | 41,400 | 6,814 | 8 K to 6.8 K (-14.97 %) |
| May 28 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 8.67 | 1,200 | 10,400 | 8,014 | 6.8 K to 8 K (+17.61 %) |
| May 28 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 34.54 | 110 | 3,799 | 6,814 | 6.9 K to 6.8 K (-1.59 %) |
| May 28 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 8.67 | 110 | 953 | 6,924 | 6.8 K to 6.9 K (+1.61 %) |
| May 22 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 8.67 | 23,873 | 206,900 | 23,722 | |
| May 22 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 21.50 | 4,327 | 93,031 | 9,519 | |
| May 22 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 34.50 | 100 | 3,450 | 6,814 | 6.9 K to 6.8 K (-1.45 %) |
| May 22 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 34.50 | 100 | 3,450 | 6,914 | 7 K to 6.9 K (-1.43 %) |
| May 22 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 34.50 | 28,000 | 966,000 | 7,014 | 35 K to 7 K (-79.97 %) |
| May 22 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 8.67 | 23,873 | 206,900 | 35,014 | 11.1 K to 35 K (+214.28 %) |
| May 22 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 21.50 | 4,327 | 93,031 | 11,141 | 6.8 K to 11.1 K (+63.50 %) |
| May 09 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | A | 31.90 | 22,500 | 717,750 | 22,500 | |
| May 09 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Grant | A | 0.00 | 3,000 | 0 | 6,814 | 3.8 K to 6.8 K (+78.66 %) |
| Apr 11 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 0.00 | 6,490 | 0 | 14,279 | |
| Apr 11 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Payment of Exercise | F | 34.57 | 2,676 | 92,509 | 3,814 | 6.5 K to 3.8 K (-41.23 %) |
| Apr 11 2013 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 0.00 | 6,490 | 0 | 6,490 | 0 to 6.5 K |
| Nov 20 2012 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | A | 21.50 | 13,846 | 297,689 | 13,846 | |
| Nov 20 2012 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | A | 0.00 | 20,769 | 0 | 20,769 |
Page: 1